Among teens with headache, 27 percent reported worsening of headaches, while 10 percent had new onset of headache
Studies included in a scoping review suggest that screening for parental depression is feasible in pediatric settings
Increased risk also seen among unaffected siblings of patients with either depression or IBD
Depression, worry about COVID-19, loneliness as strongly linked to hospitalization as high cholesterol, hypertension
States with greater increases in symptoms had fewer deaths from COVID-19 and lower women's unemployment rates
Common reasons for not seeking treatment include cost, not knowing where to go for services, fear of being committed or having to take meds
Treatments based on cognitive behavioral therapies may reduce depressive symptoms, but evidence lacking for effect on anxiety
Prevalence of smoking decreased for U.S. adults with major depressive episode, substance use disorder, or both between 2006 and 2019
No improvement seen in physical or mental health-related quality of life
Screening for MDD recommended for teens aged 12 to 18 years; anxiety screening recommended for those aged 8 to 18 years